Lonza and Israel-based Sheba Medical collaborate to use the CDMO’s manufacturing platform for point-of-care genetically engineered human CAR-T cell production.
Clintec International has opened a centre of excellence for clinical research and quality assurance capabilities as part of its headquarters expansion in Glasgow, Scotland.
Melinta Therapeutics has hired ScinoPharm to make the active pharmaceutical ingredient (API) for Baxdela, an antibiotic for skin infections that was recently approved by the US FDA.
PPD has added 4,300 square feet of new laboratory space for analytical testing of biopharmaceuticals and inhalation devices to the company’s Athlone, Ireland-based GMP facility.
Robust quality systems differentiate Biocon from other Indian manufacturers, the firm says, despite political turmoil in the Middle East and North Africa impacting first quarter 2015 sales.
CRO Parexel has shifted its attention overseas with the acquisition of Atlas Medical Services, a provider of clinical research services in Turkey, the Middle East, and North Africa.
In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.
Pharmaniaga Berhad has set up a joint venture to manufacture pharmaceuticals in Saudi Arabia citing opportunity growth in the region as a major catalyst.
Quintiles has added to its commercial services capabilities in the Middle East and North Africa (MENA) region through an agreement with UAE-based Dayarn Pharma.
Novartis is teaming up with Arab Company for Pharmaceutical Products (Arabio) to provide Saudi Arabia and surrounding regions with vaccines for common diseases.
The United States Pharmacopeial Convention (USP) and six government drug control laboratories in the Middle East and Northern Africa (MENA) join to launch a drug quality improvement Network.
Quintiles has established a joint venture with Health Kare Pharma International (HKPI) and Ramco Import and Export, focused on providing pharmaceutical contract sales and promotional services in Egypt.
The opening of a New York office will help communicate Clintec’s global reach to US Pharmaceutical according to new associate director of US business operations, Susan Pavone.
Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.
A $150m (€100m) biologics manufacturing plant is being setup in Abu Dhabi to produce therapeutics for the Middle East and North Africa, according to the Khaleej Times.
Eisai is planning to step up its clinical research presence in Asia
and has chosen Singapore as a hub from which to coordinate its
research activities.
UK-based firm BioProgress has developed novel tablet cores that
mean pills which were previously very difficult to coat can be
reformulated and easily coated using the company's innovative
TabWrap technology.
Pharmaceutical giant AstraZeneca has invested in a tablet
manufacturing plant in Egypt, which could form a launching pad for
an expansion into emerging markets.
Increased sales and price hikes helped BASF achieve record earnings
in 2005, despite substantially higher raw material prices, Europe's
subdued economy and hurricanes in the US.
India's leading biotechnology company, Bharat Biotech, has said it
intends to spend more than €10 million on the construction of a
manufacturing facility in Perak, Malaysia, to mass produce
hepatitis B, typhoid and malaria vaccines.
UK-based contract researcher Synprotec has been acquired by India's
Dishman Pharmaceuticals & Chemicals in a move that marks a
continuing expansion of the latter firm into foreign markets,
reports Phil Taylor.
Dutch biotechnology company Crucell has announced a new project
aimed at developing a vaccine for West Nile virus, a flu-like
illness that can cause a brain infection with a mortality rate of 1
per cent
